Leerink Swann upgrades Alnylam Pharmaceuticals (Nasdaq: ALNY) to Market Perform. 12-month valuation of $22/share.

Leerink analyst says, "We are assuming ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE